Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| VN |
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
13.5T VND |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
959.3B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
291.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.2B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
242.2B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151.4B USD |
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
103.6B EUR |
Loading...
|
Market Distribution
| Min | -67 046.2% |
| 30th Percentile | 1.4% |
| Median | 4% |
| 70th Percentile | 9.8% |
| Max | 1 155.9% |
Other Profitability Ratios
Dhg Pharmaceutical Joint-Stock Co
Glance View
DHG Pharmaceutical JSC engages in the production, sale, and trade of pharmaceutical products. The company is headquartered in Can Tho, Can Tho and currently employs 2,770 full-time employees. The company went IPO on 2006-12-21. The firm manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Dhg Pharmaceutical Joint-Stock Co is 16.5%, which is below its 3-year median of 17.4%.
Over the last 3 years, Dhg Pharmaceutical Joint-Stock Co’s Net Margin has decreased from 20.5% to 16.5%. During this period, it reached a low of 15.4% on Dec 31, 2024 and a high of 20.5% on Dec 31, 2022.
